Disappearance of MMR-deficient subclones after controlled IL-12 and PD-1 inhibition in a glioma patient.
McCord M, Lukas RV, Amidei C, Demars N, Gelb A, Buck J, Sachdev S, Feldman A, Tate M, Dixit K, Brat DJ, Jennings L, Horbinski C.
McCord M, et al.
Neurooncol Adv. 2021 Mar 15;3(1):vdab045. doi: 10.1093/noajnl/vdab045. eCollection 2021 Jan-Dec.
Neurooncol Adv. 2021.
PMID: 34250480
Free PMC article.
No abstract available.